100 related articles for article (PubMed ID: 2392204)
1. Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome.
Gandhi R; Thomas C
Nephron; 1990; 55(4):444. PubMed ID: 2392204
[No Abstract] [Full Text] [Related]
2. Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome.
Jones BF
Nephron; 1993; 63(4):472. PubMed ID: 8459888
[No Abstract] [Full Text] [Related]
3. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
4. In what order should one introduce cyclophosphamide or chlorambucil, cyclosporine or levamisole in a child with steroid-dependent frequently relapsing nephrotic syndrome?
Brodehl J
Pediatr Nephrol; 1993 Oct; 7(5):514. PubMed ID: 8251311
[No Abstract] [Full Text] [Related]
5. Cyclophosphamide pulse therapy in relapsing nephrotic syndrome.
Wardle EN
Nephron; 1991; 58(3):377. PubMed ID: 1896110
[No Abstract] [Full Text] [Related]
6. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
Barratt TM; Cameron JS; Chantler C; Ogg CS; Soothill JF
Arch Dis Child; 1973 Apr; 48(4):286-90. PubMed ID: 4574639
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
McCrory WW; Shibuya M; Lu WH; Lewy JE
J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
[No Abstract] [Full Text] [Related]
8. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
Cammas B; Harambat J; Bertholet-Thomas A; Bouissou F; Morin D; Guigonis V; Bendeddouche S; Afroukh-Hacini N; Cochat P; Llanas B; Decramer S; Ranchin B
Nephrol Dial Transplant; 2011 Jan; 26(1):178-84. PubMed ID: 20610527
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of nephrotic syndrome in children (author's transl)].
Schärer K
Monatsschr Kinderheilkd; 1980 Nov; 128(11):685-8. PubMed ID: 6110172
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
[TBL] [Abstract][Full Text] [Related]
12. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
Pennisi AJ; Grushkin CM; Lieberman E
Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
[TBL] [Abstract][Full Text] [Related]
14. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide therapy in the management of nephrotic syndrome.
Srivastava RN; Mayekar G; Anand R; Choudhry VP; Ghai OP
Indian Pediatr; 1974 Dec; 11(12):767-74. PubMed ID: 4448539
[No Abstract] [Full Text] [Related]
16. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
18. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
[No Abstract] [Full Text] [Related]
19. [Recent advances in therapy for nephrotic syndrome in children].
Hattori M
Nihon Jinzo Gakkai Shi; 2007; 49(2):103-7. PubMed ID: 17375617
[No Abstract] [Full Text] [Related]
20. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
Lama G
Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
